UCA1-AS1 and colorectal carcinoma: As increased LINC01764 expression is related to a poor response to FOLFOX/XELOX treatment and poor prognosis in CRC patients, we assumed that LINC01764 may be related to sensitivity to FOLFOX/XELOX therapy.